FLUTAMAB Trademark

Trademark Overview

On Friday, March 2, 2007, a trademark application was filed for FLUTAMAB with the United States Patent and Trademark Office. The USPTO has given the FLUTAMAB trademark a serial number of 77121535. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 11, 2020. This trademark is owned by OncoFluor, Inc.. The FLUTAMAB trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer
flutamab

General Information

Serial Number77121535
Word MarkFLUTAMAB
Filing DateFriday, March 2, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 11, 2020
Registration Number3747166
Registration DateTuesday, February 9, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2007

Trademark Statements

Goods and Servicespharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 11, 2020
Primary Code005
First Use Anywhere DateSunday, November 1, 2009
First Use In Commerce DateSunday, November 1, 2009

Trademark Owner History

Party NameOncoFluor, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCoronado, CA 92118
Party NameOncoFluor, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCoronado, CA 92118
Party NameOncoFluor, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoronado, CA 92118

Trademark Events

Event DateEvent Description
Friday, September 11, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, February 9, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 26, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, February 26, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, February 26, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 2, 2016TEAS SECTION 8 RECEIVED
Tuesday, February 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 9, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, January 7, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, January 4, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 27, 2009STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 24, 2009USE AMENDMENT FILED
Tuesday, November 24, 2009TEAS STATEMENT OF USE RECEIVED
Friday, May 29, 2009EXTENSION 3 GRANTED
Wednesday, May 27, 2009EXTENSION 3 FILED
Wednesday, May 27, 2009TEAS EXTENSION RECEIVED
Monday, December 1, 2008EXTENSION 2 GRANTED
Monday, November 24, 2008EXTENSION 2 FILED
Friday, November 28, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 24, 2008TEAS EXTENSION RECEIVED
Thursday, May 15, 2008EXTENSION 1 GRANTED
Monday, May 5, 2008EXTENSION 1 FILED
Monday, May 5, 2008TEAS EXTENSION RECEIVED
Tuesday, December 4, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2007NOTICE OF PUBLICATION
Friday, August 3, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 1, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 21, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 21, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 21, 2007ASSIGNED TO LIE
Thursday, July 5, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 18, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 18, 2007NON-FINAL ACTION E-MAILED
Monday, June 18, 2007NON-FINAL ACTION WRITTEN
Friday, June 15, 2007ASSIGNED TO EXAMINER
Wednesday, March 7, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

flutamab treatment cancer antibody monoclonal preparation namely pharmaceutical